Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

565 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation.
Cook G, Iacobelli S, van Biezen A, Ziagkos D, LeBlond V, Abraham J, McQuaker G, Schoenland S, Rambaldi A, Halaburda K, Rovira M, Sica S, Byrne J, Sanz RG, Nagler A, van de Donk NW, Sinisalo M, Cook M, Kröger N, De Witte T, Morris C, Garderet L. Cook G, et al. Among authors: rovira m. Haematologica. 2017 Jan;102(1):160-167. doi: 10.3324/haematol.2016.148460. Epub 2016 Sep 15. Haematologica. 2017. PMID: 27634201 Free PMC article.
Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2-3 trial.
Köhler W, Engelen M, Eichler F, Lachmann R, Fatemi A, Sampson J, Salsano E, Gamez J, Molnar MJ, Pascual S, Rovira M, Vilà A, Pina G, Martín-Ugarte I, Mantilla A, Pizcueta P, Rodríguez-Pascau L, Traver E, Vilalta A, Pascual M, Martinell M, Meya U, Mochel F; ADVANCE Study Group. Köhler W, et al. Among authors: rovira m. Lancet Neurol. 2023 Feb;22(2):127-136. doi: 10.1016/S1474-4422(22)00495-1. Lancet Neurol. 2023. PMID: 36681445 Clinical Trial.
β-Cell Regeneration Is Driven by Pancreatic Plasticity.
Holguín-Horcajo A, Sancho R, Rovira M. Holguín-Horcajo A, et al. Among authors: rovira m. Adv Anat Embryol Cell Biol. 2024;239:91-115. doi: 10.1007/978-3-031-62232-8_4. Adv Anat Embryol Cell Biol. 2024. PMID: 39283483 Review.
Update on Cytomegalovirus Infection Management in Allogeneic Hematopoietic Stem Cell Transplant Recipients. A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC).
Piñana JL, Giménez E, Vázquez L, Marcos MÁ, Guerreiro M, Duarte R, Pérez A, de Miguel C, Espigado I, González-Vicent M, Suarez-Lledó M, García-Cadenas I, Martino R, Cedillo A, Rovira M, de la Cámara R, Navarro D, Solano C. Piñana JL, et al. Among authors: rovira m. Mediterr J Hematol Infect Dis. 2024 Sep 1;16(1):e2024065. doi: 10.4084/MJHID.2024.065. eCollection 2024. Mediterr J Hematol Infect Dis. 2024. PMID: 39258183 Free PMC article. Review.
Higher survival following transplantation with a mismatched unrelated donor with posttransplant cyclophosphamide-based graft-versus-host disease prophylaxis than with double unit umbilical cord blood in patients with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Baron F, Labopin M, Versluis J, Vydra J, von dem Borne PA, Nicholson E, Blaise D, Protheroe R, Kulagin A, Bulabois CE, Rovira M, Chevallier P, Forcade E, Byrne J, Sanz J, Ruggeri A, Mohty M, Ciceri F. Baron F, et al. Among authors: rovira m. Am J Hematol. 2024 Aug 31. doi: 10.1002/ajh.27466. Online ahead of print. Am J Hematol. 2024. PMID: 39215605
Outcomes of older adults undergoing allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide based prophylaxis.
Murillo V, Charry P, Suárez-Lledó M, Guardia L, Moreno C, Cid J, Lozano M, Pedraza A, Salinas R, Vilas V, Duch M, Díaz-Beya M, Rosiñol L, Esteve J, Carreras E, Fernández-Avilés F, Martínez C, Rovira M, Salas MQ. Murillo V, et al. Among authors: rovira m. Eur J Haematol. 2024 Aug 14. doi: 10.1111/ejh.14291. Online ahead of print. Eur J Haematol. 2024. PMID: 39143681
Safety and efficacy of G-CSF after allogeneic hematopoietic cell transplantation using post-transplant cyclophosphamide: clinical and in vitro examination of endothelial activation.
Escribano-Serrat S, Pedraza A, Suárez-Lledó M, Charry P, De Moner B, Martinez-Sanchez J, Ramos A, Ventosa-Capell H, Moreno C, Guardia L, Monge-Escartín I, Riu G, Carcelero E, Cid J, Lozano M, Gómez P, García E, Martín L, Carreras E, Fernández-Avilés F, Martínez C, Rovira M, Salas MQ, Díaz-Ricart M. Escribano-Serrat S, et al. Among authors: rovira m. Bone Marrow Transplant. 2024 Aug 8. doi: 10.1038/s41409-024-02388-y. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 39117736
Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study.
Juárez A, Salas MQ, Pedraza A, Suárez-Lledó M, Rodríguez-Lobato LG, Solano MT, Serrahima A, Nomdedeu M, Cid J, Lozano M, Charry P, Arcarons J, Llobet N, Rosiñol L, Fernández-Avilés F, Rovira M, Martínez C. Juárez A, et al. Among authors: rovira m. Cancers (Basel). 2024 Jul 17;16(14):2567. doi: 10.3390/cancers16142567. Cancers (Basel). 2024. PMID: 39061206 Free PMC article.
Older MRD vs. younger MUD in patients older than 50 years with AML in remission using post-transplant cyclophosphamide.
Piemontese S, Labopin M, Choi G, Broers AEC, Peccatori J, Meijer E, Van Gorkom G, Rovira M, Pascual Cascon MJ, Sica S, Vydra J, Kulagin A, Spyridonidis A, Nagler A, Bazarbachi A, Savani B, Brissot E, Sanz J, Mohty M, Ciceri F. Piemontese S, et al. Among authors: rovira m. Leukemia. 2024 Sep;38(9):2016-2022. doi: 10.1038/s41375-024-02359-8. Epub 2024 Jul 24. Leukemia. 2024. PMID: 39048722
565 results